bit.bio Wins Honours for Innovation in Synthetic Biology and Exceptional Business Growth.
12.09.2024bit.bio Wins Honours for Innovation in Synthetic Biology and Exceptional Business Growth.
bit.bio Wins Honours for Innovation in Synthetic Biology and Exceptional Business Growth.
12.09.2024bit.bio Wins Honours for Innovation in Synthetic Biology and Exceptional Business Growth.
bit.bio appoints new Chief Financial Officer, Przemek Obloj
31.07.2024bit.bio launches panel of 16 neurodegenerative disease models for research and drug discovery in Alzheimer’s and Parkinson’s disea...
24.07.2024Presenting our first annual sustainability report, detailing our Corporate Sustainability Strategy and progress towards our aligne...
12.07.2024bit.bio CEO Dr Mark Kotter was interviewed by Jon Chee on the Biotech Startups Podcast.
11.07.2024CEO Mark Kotter, shares insights in an exclusive interview with Genetic Engineering & Biotechnology News about the revolutionary C...
03.07.2024CEO and founder, Mark Kotter, recently joined the ScaleUp Radio podcast!
27.06.2024bit.bio launches ioAstrocytes, advancing how scientists can model the human brain.
20.06.2024Hosts David Wood and Calum Chace and bit.bio CEO Mark Kotter discusses the concept of programmable biology and cultured meat.
13.06.2024